Efficacy of Therapy With the Spironolactone Pills Compared to Minoxidil Lotion in Female Pattern Hair Loss

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Female Pattern Hair Loss Clinical Trial

Official title:
Efficacy of Therapy With the Anti-androgen Spironolactone Compared to Topical Minoxidil in Female Pattern Hair Loss

Status Completed

Clinical Trial Summary

This study evaluates the efficacy of therapy with the anti-androgen spironolactone compared to topical minoxidil in female pattern hair loss.

n/a

NCT number	NCT00175617
Study type	Interventional
Source	University of British Columbia
Contact
Status	Completed
Phase	Phase 2
Start date	September 2005
Completion date	March 9, 2009

See also
Status	Clinical Trial	Phase
Completed	`NCT04090801` - Comparison of Topical Minoxidil 5% in Ethanol Plus Propylene Glycol Versus Minoxidil 5% in Ethanol Alone in Treatment of Women With Female Pattern Hair Loss	Phase 4
Withdrawn	`NCT02486848` - Minoxidil Dose Response Study in Females Identified Through IVD Testing as Non-Responders to 5% Topical Minoxidil	N/A
Completed	`NCT00958750` - Efficacy and Safety Study to Compare Two Minoxidil Formulations on Women With Androgenetic Alopecia	Phase 3
Completed	`NCT02206802` - Minoxidil Response Testing in Females With Female Pattern Hair Loss
Completed	`NCT01900041` - A Study to Evaluate the Superiority, Efficacy and Tolerability of Combination Pantovigar With 2% Minoxidil vs 2% Minoxidil in Women With Female Pattern Hair Loss	Phase 2